Risk stratification of patient in Brugada syndrome: Risk score accuracy
نویسندگان
چکیده
منابع مشابه
Risk Stratification in Brugada Syndrome
Silvia G. Priori, MD, PHD,*†‡ Maurizio Gasparini, MD,§ Carlo Napolitano, MD, PHD,*‡ Paolo Della Bella, MD, Andrea Ghidini Ottonelli, MD,¶ Biagio Sassone, MD,# Umberto Giordano, MD,** Carlo Pappone, MD,†† Giosuè Mascioli, MD,‡‡ Guido Rossetti, MD,§§ Roberto De Nardis MD, Mario Colombo, MS¶¶ Pavia, Rozzano, Milano, Lido di Camaiore, Bentivoglio, Palermo, Ravenna, Bergamo, Cuneo, and Vicenza, Ital...
متن کاملRisk stratification in Brugada syndrome.
Kathryn A Glatter*, Nipavan Chiamvimonvat, Matti Viitasalo, Qing Wang, and Dipika Tuteja Department of Cardiology,University of California, Davis, Sacramento, CA 95817, USA (KAG, NC, DT); Department of Cardiology,Helsinki University Hospital, Helsinki, Finland (MV); and Center for Cardiovascular Genetics and Department of Molecular Cardiology Cardiology, Cleveland Clinic Foundation, Cleveland, ...
متن کاملRisk Stratification in Brugada Syndrome: Role of Programmed Electrical Stimulation
Brugada syndrome (BS) is an arrhythmogenic disease characterized by a typical electrocardiographic finding (type 1 Brugada electrocardiogram [ECG]) and an increased risk for sudden cardiac death (SCD) due to polymorphic ventricular tachycardia or ventricular fibrillation (VF). Risk stratification remains a challenge, especially in cases without documented cardiac arrest or VF. The role of progr...
متن کاملBrugada syndrome: Controversies in Risk stratification and Management
In the 18 years since the first description of Brugada Syndrome in a small series of cardiac arrest survivors it has become evident that there is a marked spectrum in phenotype and prognosis. An internal cardiac defibrillator (ICD) is the only established therapy but is associated with significant morbidity. A number of registries have published their data, but risk stratification, particularly...
متن کاملClinical diagnosis and risk stratification in patients with Brugada syndrome.
In patients with Brugada syndrome (BRS), especially those who are asymptomatic, preclinical diagnosis and risk stratification are vital to the prevention of the fatal ventricular arrhythmias. The initial optimism that a diagnosis of BRS could be made simply on the basis of distinct electrocardiographic (ECG) changes (see the following text) has been tempered, both by a high incidence of false-p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Cardiovascular Diseases Supplements
سال: 2018
ISSN: 1878-6480
DOI: 10.1016/j.acvdsp.2018.02.039